ReviewGut microbes reports2026
Microbiome-targeted dietary therapy in health and disease: Challenges, opportunities, and pathways forward.
Review in Gut microbes reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The gut microbiome has an established role in health and disease, and can be manipulated by diet, positioning microbiome-targeted dietary therapies as potential therapeutics. Mounting evidence supports dietary patterns rich in fermentable fibers and lower in nutrient-poor processed foods; however, there are individual, local, and system-wide complexities to adopting and sustaining dietary change as part of therapeutic dietary strategies. Wider adoption of diet therapy is also limited by critical factors that interfere and influence treatment outcomes, the most significant being inter-individual variability in response to dietary therapy, which remains poorly characterized and understood, hindering advancements in precision nutrition. This review examines the role of the gut microbiome in health and disease and describes barriers and solutions for developing and implementing microbiome-targeted dietary interventions as therapeutic strategies. We organize these barriers into three domains: biological, behavioral, and policy and systems, moving from molecular and individual-level mechanisms to population-level systems, and identify evidence gaps and candidate measurable outcomes to guide future research and dietary guideline development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.